English
简体中文
Total: £ 56.28
Published Date: 2025-11-05 | Pages: 121 | Tables: 123 | Service & Software
The global Gene Sequence Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Molecular Biology accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gene Sequence Testing Service leading manufacturers including Roche, Johnson & Johnson, Illumina, Thermo Fisher Scientific, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, GE Healthcare Life Sciences, Abbott Laboratories, etc., dominate supply; the top five capture approximately % of global revenue, with Roche leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gene Sequence Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Roche
Johnson & Johnson
Illumina
Thermo Fisher Scientific
Beckman Coulter
Pacific Biosciences
Oxford Nanopore
GE Healthcare Life Sciences
Abbott Laboratories
Segment by Type
Emulsion PCR
Bridge Amplification
Single-Molecule
Segment by Application
Molecular Biology
Evolutionary Biology
Metagenomics
Medicine
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Gene Sequence Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Gene Sequence Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gene Sequence Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Emulsion PCR
1.2.3 Bridge Amplification
1.2.4 Single-Molecule
1.3 Market Segmentation by Application
1.3.1 Global Gene Sequence Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Molecular Biology
1.3.3 Evolutionary Biology
1.3.4 Metagenomics
1.3.5 Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Sequence Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Gene Sequence Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gene Sequence Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gene Sequence Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Emulsion PCR Market Size by Players
3.3.2 Bridge Amplification Market Size by Players
3.3.3 Single-Molecule Market Size by Players
3.4 Global Gene Sequence Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gene Sequence Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gene Sequence Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gene Sequence Testing Service Market Size by Type (2020-2031)
6.4 North America Gene Sequence Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gene Sequence Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gene Sequence Testing Service Market Size by Type (2020-2031)
7.4 Europe Gene Sequence Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gene Sequence Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gene Sequence Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Gene Sequence Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gene Sequence Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gene Sequence Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Gene Sequence Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gene Sequence Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gene Sequence Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Gene Sequence Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gene Sequence Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Business Overview
11.1.3 Roche Gene Sequence Testing Service Product Features and Attributes
11.1.4 Roche Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Roche Gene Sequence Testing Service Revenue by Product in 2024
11.1.6 Roche Gene Sequence Testing Service Revenue by Application in 2024
11.1.7 Roche Gene Sequence Testing Service Revenue by Geographic Area in 2024
11.1.8 Roche Gene Sequence Testing Service SWOT Analysis
11.1.9 Roche Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Gene Sequence Testing Service Product Features and Attributes
11.2.4 Johnson & Johnson Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Johnson & Johnson Gene Sequence Testing Service Revenue by Product in 2024
11.2.6 Johnson & Johnson Gene Sequence Testing Service Revenue by Application in 2024
11.2.7 Johnson & Johnson Gene Sequence Testing Service Revenue by Geographic Area in 2024
11.2.8 Johnson & Johnson Gene Sequence Testing Service SWOT Analysis
11.2.9 Johnson & Johnson Recent Developments
11.3 Illumina
11.3.1 Illumina Corporation Information
11.3.2 Illumina Business Overview
11.3.3 Illumina Gene Sequence Testing Service Product Features and Attributes
11.3.4 Illumina Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Illumina Gene Sequence Testing Service Revenue by Product in 2024
11.3.6 Illumina Gene Sequence Testing Service Revenue by Application in 2024
11.3.7 Illumina Gene Sequence Testing Service Revenue by Geographic Area in 2024
11.3.8 Illumina Gene Sequence Testing Service SWOT Analysis
11.3.9 Illumina Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Gene Sequence Testing Service Product Features and Attributes
11.4.4 Thermo Fisher Scientific Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Thermo Fisher Scientific Gene Sequence Testing Service Revenue by Product in 2024
11.4.6 Thermo Fisher Scientific Gene Sequence Testing Service Revenue by Application in 2024
11.4.7 Thermo Fisher Scientific Gene Sequence Testing Service Revenue by Geographic Area in 2024
11.4.8 Thermo Fisher Scientific Gene Sequence Testing Service SWOT Analysis
11.4.9 Thermo Fisher Scientific Recent Developments
11.5 Beckman Coulter
11.5.1 Beckman Coulter Corporation Information
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Gene Sequence Testing Service Product Features and Attributes
11.5.4 Beckman Coulter Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Beckman Coulter Gene Sequence Testing Service Revenue by Product in 2024
11.5.6 Beckman Coulter Gene Sequence Testing Service Revenue by Application in 2024
11.5.7 Beckman Coulter Gene Sequence Testing Service Revenue by Geographic Area in 2024
11.5.8 Beckman Coulter Gene Sequence Testing Service SWOT Analysis
11.5.9 Beckman Coulter Recent Developments
11.6 Pacific Biosciences
11.6.1 Pacific Biosciences Corporation Information
11.6.2 Pacific Biosciences Business Overview
11.6.3 Pacific Biosciences Gene Sequence Testing Service Product Features and Attributes
11.6.4 Pacific Biosciences Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 Pacific Biosciences Recent Developments
11.7 Oxford Nanopore
11.7.1 Oxford Nanopore Corporation Information
11.7.2 Oxford Nanopore Business Overview
11.7.3 Oxford Nanopore Gene Sequence Testing Service Product Features and Attributes
11.7.4 Oxford Nanopore Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Oxford Nanopore Recent Developments
11.8 GE Healthcare Life Sciences
11.8.1 GE Healthcare Life Sciences Corporation Information
11.8.2 GE Healthcare Life Sciences Business Overview
11.8.3 GE Healthcare Life Sciences Gene Sequence Testing Service Product Features and Attributes
11.8.4 GE Healthcare Life Sciences Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 GE Healthcare Life Sciences Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Corporation Information
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Gene Sequence Testing Service Product Features and Attributes
11.9.4 Abbott Laboratories Gene Sequence Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Abbott Laboratories Recent Developments
12 Gene Sequence Testing ServiceIndustry Chain Analysis
12.1 Gene Sequence Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gene Sequence Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gene Sequence Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Gene Sequence Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gene Sequence Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gene Sequence Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gene Sequence Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gene Sequence Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Gene Sequence Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Gene Sequence Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Gene Sequence Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Sequence Testing Service as of 2024)
Table 11. Global Gene Sequence Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Gene Sequence Testing Service Companies Headquarters
Table 13. Global Gene Sequence Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Gene Sequence Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Gene Sequence Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Gene Sequence Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Gene Sequence Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Gene Sequence Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Gene Sequence Testing Service Growth Accelerators and Market Barriers
Table 25. North America Gene Sequence Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Gene Sequence Testing Service Growth Accelerators and Market Barriers
Table 27. Europe Gene Sequence Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Gene Sequence Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Gene Sequence Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Gene Sequence Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Gene Sequence Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Gene Sequence Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Gene Sequence Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Roche Corporation Information
Table 35. Roche Description and Major Businesses
Table 36. Roche Product Features and Attributes
Table 37. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Roche Revenue Proportion by Product in 2024
Table 39. Roche Revenue Proportion by Application in 2024
Table 40. Roche Revenue Proportion by Geographic Area in 2024
Table 41. Roche Gene Sequence Testing Service SWOT Analysis
Table 42. Roche Recent Developments
Table 43. Johnson & Johnson Corporation Information
Table 44. Johnson & Johnson Description and Major Businesses
Table 45. Johnson & Johnson Product Features and Attributes
Table 46. Johnson & Johnson Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Johnson & Johnson Revenue Proportion by Product in 2024
Table 48. Johnson & Johnson Revenue Proportion by Application in 2024
Table 49. Johnson & Johnson Revenue Proportion by Geographic Area in 2024
Table 50. Johnson & Johnson Gene Sequence Testing Service SWOT Analysis
Table 51. Johnson & Johnson Recent Developments
Table 52. Illumina Corporation Information
Table 53. Illumina Description and Major Businesses
Table 54. Illumina Product Features and Attributes
Table 55. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Illumina Revenue Proportion by Product in 2024
Table 57. Illumina Revenue Proportion by Application in 2024
Table 58. Illumina Revenue Proportion by Geographic Area in 2024
Table 59. Illumina Gene Sequence Testing Service SWOT Analysis
Table 60. Illumina Recent Developments
Table 61. Thermo Fisher Scientific Corporation Information
Table 62. Thermo Fisher Scientific Description and Major Businesses
Table 63. Thermo Fisher Scientific Product Features and Attributes
Table 64. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 66. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 67. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 68. Thermo Fisher Scientific Gene Sequence Testing Service SWOT Analysis
Table 69. Thermo Fisher Scientific Recent Developments
Table 70. Beckman Coulter Corporation Information
Table 71. Beckman Coulter Description and Major Businesses
Table 72. Beckman Coulter Product Features and Attributes
Table 73. Beckman Coulter Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Beckman Coulter Revenue Proportion by Product in 2024
Table 75. Beckman Coulter Revenue Proportion by Application in 2024
Table 76. Beckman Coulter Revenue Proportion by Geographic Area in 2024
Table 77. Beckman Coulter Gene Sequence Testing Service SWOT Analysis
Table 78. Beckman Coulter Recent Developments
Table 79. Pacific Biosciences Corporation Information
Table 80. Pacific Biosciences Description and Major Businesses
Table 81. Pacific Biosciences Product Features and Attributes
Table 82. Pacific Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Pacific Biosciences Recent Developments
Table 84. Oxford Nanopore Corporation Information
Table 85. Oxford Nanopore Description and Major Businesses
Table 86. Oxford Nanopore Product Features and Attributes
Table 87. Oxford Nanopore Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Oxford Nanopore Recent Developments
Table 89. GE Healthcare Life Sciences Corporation Information
Table 90. GE Healthcare Life Sciences Description and Major Businesses
Table 91. GE Healthcare Life Sciences Product Features and Attributes
Table 92. GE Healthcare Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. GE Healthcare Life Sciences Recent Developments
Table 94. Abbott Laboratories Corporation Information
Table 95. Abbott Laboratories Description and Major Businesses
Table 96. Abbott Laboratories Product Features and Attributes
Table 97. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Abbott Laboratories Recent Developments
Table 99. Raw Materials Key Suppliers
Table 100. Distributors List
Table 101. Market Trends and Market Evolution
Table 102. Market Drivers and Opportunities
Table 103. Market Challenges, Risks, and Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Sequence Testing Service Product Picture
Figure 2. Global Gene Sequence Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Emulsion PCR Product Picture
Figure 4. Bridge Amplification Product Picture
Figure 5. Single-Molecule Product Picture
Figure 6. Global Gene Sequence Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Molecular Biology
Figure 8. Evolutionary Biology
Figure 9. Metagenomics
Figure 10. Medicine
Figure 11. Others
Figure 12. Gene Sequence Testing Service Report Years Considered
Figure 13. Global Gene Sequence Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 15. Global Gene Sequence Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Gene Sequence Testing Service Revenue Market Share by Region (2020-2031)
Figure 17. Global Gene Sequence Testing Service Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Emulsion PCR Revenue Market Share by Player in 2024
Figure 20. Bridge Amplification Revenue Market Share by Player in 2024
Figure 21. Single-Molecule Revenue Market Share by Player in 2024
Figure 22. Global Gene Sequence Testing Service Revenue Market Share by Type (2020-2031)
Figure 23. Global Gene Sequence Testing Service Revenue Market Share by Application (2020-2031)
Figure 24. North America Gene Sequence Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Gene Sequence Testing Service Revenue (US$ Million) in 2024
Figure 26. North America Gene Sequence Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Gene Sequence Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Gene Sequence Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Gene Sequence Testing Service Revenue (US$ Million) in 2024
Figure 33. Europe Gene Sequence Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Gene Sequence Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. France Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Gene Sequence Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Gene Sequence Testing Service Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Gene Sequence Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Gene Sequence Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. India Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Gene Sequence Testing Service Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Gene Sequence Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Gene Sequence Testing Service Revenue (US$ Million) in 2024
Figure 56. Central and South America Gene Sequence Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Gene Sequence Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Gene Sequence Testing Service Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Gene Sequence Testing Service Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Gene Sequence Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Gene Sequence Testing Service Revenue (US$ Million) in 2024
Figure 62. South America Gene Sequence Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Gene Sequence Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Gene Sequence Testing Service Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Gene Sequence Testing Service Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Gene Sequence Testing Service Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Gene Sequence Testing Service Revenue (2020-2025) & (US$ Million)
Figure 68. Gene Sequence Testing Service Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
